The application of real-world evidence (RWE) as a healthcare decision-making tool has the potential to significantly improve patient outcomes, patient care, reduce costs, and boost efficiencies in health care systems. The current drive to adopt new medications, devices and technology is encouraged by increasing acceptance of RWE’s value and the FDA’s support of its use. However, multiple barriers continue to impede widespread implementation. Download the full whitepaper here.
You are here: / / [Whitepaper] How Can Real-World Evidence Support Adoption of New Technology?